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Abstract 
 
Background: DNA-intercalating drugs are planar molecules with several fused aromatic rings that 
form stacks between DNA base pairs, reducing the opening and unwinding of the double helix. 
Recently, interest on intercalating agents has moved in the search for new ligands to G-quadruplex 
structures. 
Methods: The DNA binding properties of 4-aminoproline oligomers functionalized with one, two or 
three units of acridine and/or quindoline have been analyzed by competitive dialysis. A 
NMR/molecular dynamics study was performed on G-quadruplex telomeric sequence and the 4-
aminoproline dimer carrying two quindolines. A model of the complex with the telomeric DNA 
quadruplex is described. 
Results and conclusions: A selectivity of quindoline 4-aminoproline oligomers for G-quadruplex 
and triplex structures was observed, especially for those quadruplex sequences found in telomeres 
and in the promoter regions of c-myc and bcl-2 oncogenes. In this model the quindoline dimer is 
stabilized by π–π stacking interactions between the aromatic rings of the ligand and the nucleobases 
of the telomeric sequence that are located above and below the molecule. 
General significance: The results of this work can be used for the design of new molecules with 
high affinity to telomeres which may have anticancer properties. 
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1. Introduction 
DNA-intercalating drugs are planar molecules formed by several fused aromatic rings that form 
stacks between DNA base pairs, thus reducing the opening and unwinding of the double helix. Each 
intercalating drug binds strongly to particular base pairs due to several interactions, ranging from 
van der Waals interactions to the formation of hydrogen bonds with adjacent nucleobases [1, 2]. 
The selectivity of intercalating drugs may be improved by linking several intercalating units. 
Various authors have described the synthesis of bis- or tris-intercalating drugs with promising 
activity and selectivity [3, 4].  
Recently, interest on intercalating agents has moved in the search for new ligands to G-
quadruplex structures [5]. This structure motif is formed by the planar association of four guanines 
in a cyclic Hoosgsteen hydrogen bonding tetrad. Guanine rich sequences are able to form G-
 3
quadruplex structures which have been found in telomeres [6] and in transcriptional regulatory 
regions of important oncogenes such as c-myc, and c-kit, [7, 8]. Ligands that selectively bind and 
stabilize these structures have become interesting anticancer drugs [9]. G-quadruplex stabilization 
occurs in most of the cases by π-π stacking and electrostatic interaction. G-quadruplex ligands are 
normally planar aromatic molecules that are prone to stacking with G-tetrads [10]. Some of them 
are also positively charged or have hydrophilic groups to favour electrostatic interaction [11]. 
 In previous papers we have described the preparation of sequence specific oligomers of 
DNA-intercalating drugs using protocols based on solid-phase synthesis in an attempt to facilitate 
the preparation of compounds with improved DNA-binding selectivity [12, 13]. The preparation of 
several acridine oligomers linked through 2-aminoethylglycine units by solid-phase synthesis 
protocols was also described [14]. These compounds show a clear affinity for several DNA G-
quadruplex structures. Here we describe the DNA-binding properties of a complete series of 4-
aminoproline oligomers carrying up to three units of acridine and quindoline molecules. 
Competitive dialysis experiments show a very high affinity of quindoline 4-aminoproline oligomers 
for G-quadruplex especially those quadruplex sequences found in the promoter regions of c-myc 
[15] and bcl-2 [16, 17] oncogenes.  A detailed NMR / molecular dynamics study was performed on 
G-quadruplex telomeric sequence and the dimer quindoline-quindoline which is the oligomer with 
higher affinity for quadruplexes. A model of the complex that explains the affinity of the quindoline 
dimer with the DNA quadruplex is described. 
 
2. Materials and Methods 
 
2.1. Compounds 
(1) Acridine-9-carboxylic acid, (2) 2-(acridine-9-carboxamide) acetic acid, (3) 10H-
Indolo[3,2b]quinoline-11-carboxylic acid, (4) 2-(10H-Indolo[3,2b]quinoline-11-carboxamide) 
acetic acid and (5-18) acridine and quindoline 4-aminoproline backbone oligomers were 
synthesized according to published procedures [13]. Their formulas are shown in Fig. 1. 
 
2.2. Oligonucleotide Synthesis.  
All the standard phosphoroamidites and reagents for DNA synthesis were purchased from Applied 
Biosystems and from Link Technologies. The synthesis of the oligonucleotides was performed at 1 
µmol scale on an Applied Biosystem DNA/RNA 3400 synthesizer by solid-phase 2-
cyanoethylphosphoroamidite chemistry. The following sequences were prepared: T20: d(5’-TTT 
TTT TTT TTT TTT TTT TT-3’), 24bclc: d(5’-CCC GCC CCC TTC CTC CCG CGC CCG-3’), 6-
 4
mer: d(5’-CGA TGC-3’), Dickerson: d(5’-CGC GAA TTC GCG-3’), ds26: d(5’-CAA TCG GAT 
CGA ATT CGA TCC GAT TG-3’), GA triplex : d(5’-GAA AGA GAG GAG GCC TTT TTG 
GAG GAG AAG-3’) + d(5’-CCT CCT CTC TTT C-3’), TC triplex: d(5’- CCT CCT CTC TTT 
CCC TTT TTC TTT CTC TCC TCC-3’) + d(5’- GAA AGA GAG GAG G-3’), TG4T: d(5’-TGG 
GGT-3’), TBA: d(5’- GGT TGG TGT GGT TGG-3’), HT24: d(5’- TAG GGT TAG GGT TAG 
GGT TAG GGT-3’), T2AG3: d(5’-TTA GGG-3’), 24bcl: d(5’- CGG GCG CGG GAG GAA GGG 
GGC GGG-3’), cmyc: d(5’- GGG GAG GGT GGG GAG GGT GGG GAA GGT GGG G-3’). The 
resulting oligonucleotides were purified by HPLC and desalted in a Sephadex (NAP-10) G25 
column.   
 
2.3. Competitive Dialysis Assays. 
A total 200 mL of the dialysate solution containing 1µM compound was used for each 
competition dialysis assay. A volume of 100 1µL at 50µM monomeric unit of each of 
oligonucleotide sequence was placed in dialysis unit. Potassium phosphate buffer containing 
185mM NaCl, 185mM KCl, 2mM NaH2PO4, 1mM Na2EDTA and 6mM Na2HPO4 at pH 7 was 
used for all experiments. 
The samples were allowed to equilibrate with continuous stirring at room temperature 
overnight. Dialysis samples were removed to an Eppendorf tube. In order to measure the compound 
entered in the dialysis unit, dialysis samples were degraded to liberate the derivate as described 
previously [14]. 
Finally, the fluorescence of each samples was measured (λex and λem  were set to 252 and 435 nm in 
acridine derivates and 276 and 500 nm in quindoline derivates) and normalized for each compound.  
 
2.4 NMR Spectroscopy  
The NMR spectra were recorded by Bruker AV-600 spectrometer operating at a frequency 
of 600.10 MHz for 1H. 1H spectra were recorded at variable temperature ranging from 5°C to 75°C. 
1H chemical shifts (δ) were measured in ppm and referenced to external DSS (2,2-dimethyl-2-
silapentane-5-sulfonate sodium salt) set at 0.00 ppm. Estimated accuracy for protons is within 0.02 
ppm. 
   The samples for NMR measurements were dissolved in 500 µl H2O/D2O (9:1) containing 25 mM 
KH2PO4, 150 mM KCl and 1 mM EDTA (pH 6.7) for the quadruplex d(5’-TTA GGG-3’)4 and 
containing 10 mM KH2PO4, 70 mM KCl and 0.2 mM EDTA (pH 7.0) for the double helix d(5’-
CGA TCG-3’)2. The final concentration of the oligonucleotide solutions ranged between 0.6-0.7  
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mM. A stock solution of 9 and 3 was prepared in DMSO-d6 at the concentration of 6 and 12.5 mM, 
respectively. 
NMR titration was performed by adding increasing amounts of drugs to the oligonucleotides 
solution at R= [ligand]/[DNA] ratio from 0 to 0.75 (after this value the drug precipitates) for 9 and 
from 0 to 3.0 for 3. 
Standard homonuclear 2D-NMR experiments were performed to assign the resonances of 
the complexes, including DQF-COSY, TOCSY and NOESY [18, 19]. The mixing times were set at 
150 ms and 300 ms for NOESY and 60 ms for TOCSY. For samples in H2O, the excitation 
sculpting sequences from standard Bruker pulse program libraries were employed. 
Typically, 2048 x 1024 data points were acquired using TPPI and transformed to a final 4K 
x 4K real data matrix after apodisation with a 90° and 90°-shifted sine-bell squared function in f2- 
and f1-domain, respectively. Baseline correction was achieved by a 5th-degree polynomial function.  
The sequential assignments in free and bound oligonucleotides were performed by applying 
well established procedures for the analysis of double stranded and quadruplex structures.   
The program Sparky [20] was used to assign the NOESY cross-peaks. The d(5’-TTA GGG-3’)4 and 
d(5’-CGAT CG-3’)2 NMR spectra were previously assigned [21, 22]. 
 
2.5 Molecular Modelling 
The structure of compound 9 was built using a Silicon Graphics 4D35GT workstation 
running the Insight II and Discover software and was generated using standard bond lengths and 
angles. Molecular mechanics (MM) and molecular dynamics (MD) was carried out using both 
CVFF and AMBER forcefield. Molecular docking experiments were performed on an Apple® 
QuadXeon MacPro workstation with Autodock 4.0. This software uses an empirical scoring 
function based on the free energy of binding [23, 24]. Among the stochastic search algorithms 
offered by the Autodock suite, we chose the Lamarckian Genetic Algorithm (LGA) which combines 
global search (Genetic Algorithm alone) to local search (Solis and Wets algorithm [25]). Genetic 
algorithms are based on the evolutionary concept in which the solution to an adaptive problem is 
spread among a genetic pool. In molecular docking, the ‘solution’ corresponds to the best binding 
position for the ligand, and it is represented by a ‘chromosome’ file containing translation, 
orientation, and torsion ‘genes’. Basically, a genetic algorithm creates a randomly placed population 
of individuals (ligands) and then applies cycles of genetic operators (mutation and crossover) giving 
rise to new generations until a suitable solution is achieved. The ‘solutions’ are evaluated through 
their free energy of binding and (for 9) looking at their agreement with the NOE data. The small 
molecule compounds (3 and 9) and the quadruplex (obtained from Protein Data Bank 
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[http://www.rcsb.org], PDB code 1NP9) were processed using the Autodock Tool Kit (ADT) [26]. 
Gasteiger–Marsili charges [27] were loaded on the small molecules in ADT and Cornell parameters 
were used for the phosphorous atoms in the DNA. Solvation parameters were added to the final 
macromolecule structure using Addsol utility of Autodock. Each docking consisted of an initial 
population of 50 randomly placed individuals, a maximum number of 200 energy evaluations, a 
mutation rate of 0.02, a crossover rate of 0.80, and an elitism value of 1. For the local search, the so-
called pseudo-Solis and Wets algorithm was applied using a maximum of 250 iterations per local 
search. The probability of performing local search on an individual in the population was 0.06 and 
the maximum number of consecutive failures before doubling or halving the local step size was 4. 
Fifty independent docking runs were carried out for each ligand. The grid maps representing the 
system in the actual docking process were calculated with Autogrid. The grids (one for each atom 
type in the ligand, plus one for electrostatic interactions) were chosen to be sufficiently large to 
include the entire width of the DNA fragment in which the original inhibitor was posed, together 
with a portion of minor and major grooves.  The simpler intermolecular energy function based on 
the Weiner force field in Autodock was used to score the docking results. Results differing by less 
than 1.0 Å in positional root-mean-square deviation (rmsd) were clustered together and represented 
by the result with the most favourable free energy of binding. Since we could not use rmsd as the 
only accuracy criterion, we opted for a more subjective yet more representative criterion, which was 
to classify the resulting binding mode by consistence with the NOE results and visual inspection as 
intercalation, minor groove binding, or others (major groove binding, interaction with phosphate 
groups and so on).  
 
Results and discussion 
 
3.1. Competitive Dialysis Studies 
To evaluate the selectivity and the affinity of acridine and quindoline derivates for different DNA 
structures, we performed a competive dialysis experiment using 11 nucleic acid structures [14].  
As models for single stranded structures we used T20 and 24bclc. As duplexes we used the self-
complementary sequences Dickerson-Drew dodecamer (Dickerson) and a 26 mer (ds26). A parallel 
triplex (TC triplex) and an antiparallel triplex (GA triplex) were also prepared by mixing a hairpin 
Watson-Crick sequence and the corresponding triplex-forming sequence. Finally, the following G-
quadruplex sequences were prepared: the tetramolecular parallel G-quadruplex TG4T [28], the 
antiparallel thrombin-binding aptamer (TBA) [29], the human telomere sequence (HT24) [30], and 
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the promoter sequences of c-myc (cmyc) [15] and bcl-2 (24bcl) [16, 17]. The amount of the bound 
ligand was directly proportional to the binding constant for each DNA structure [31, 32]. 
Fig. 2 displays the oligonucleotide affinity for each compound. Fig. 2A showed the results for 
acridine derivates 1, 2, 5, 6 and 7. Acridine-9-carboxylic 1 interacts only with duplex ds26, the 
derivate 2 with a glycine residue, induced a change in the affinity showing a slight quadruplex 
preference, in particular for cmyc and 24bcl. On the contrary, the acridine 4-aminoproline 
oligomers 5, 6 and 7 only interacts with quadruplex structures.  
Fig. 2B shows that quindoline-11-carboxylic acid 3, quindoline-11-carboxamide acetic acid 4 
monomer 8 and trimer 10 derivatives do not present any selectivity. The affinity and selectivity for 
the quadruplex structures increases up in the dimer 9. The oligonucleotide affinity and selectivity 
drop down in the mixed dimers 11 and 12 (Fig. 2C). No selectivity and affinity improvement are 
observed for the mixed trimers 13-18 (Fig. 2D) compared with the mixed dimers. 
 
3.2. 1H NMR experiments and molecular modeling on the [9]/[(T2AG3)4] complex 
 
On the basis of dialysis studies compound 9 demonstrated the higher affinity and selectivity for the 
quadruplex structures studied in this work. In order to study in depth this binding, compound 9, 
which had the higher affinity for quadruplex structures, was titrated into a solution of quadruplex 
model (T2AG3)4 contained in the human telomere sequence and the resulting mixtures were 
analyzed by 1H-NMR. T2AG3 is short model sequence contained in HT24 oligonucleotide. This 
oligonucleotide has been used previously for NMR characterization of drug binding on telomeric 
DNA sequences [33]. The short oligonucleotide has a more simple NMR spectrum than HT24 
sequence facilitating the study of the interactions of the drug with the DNA sequence. 
We performed competitive dialysis experiments with compound 9 including the T2AG3 
oligonucleotide (Figure 1S supplementary section). The affinity of compound 9 for HT24 is slightly 
higher than T2AG3 but it is in the range of the high affinity group that includes quadruplex forming 
oligonucleotide: HT24, cmyc and 24bcl sequences.  
Moreover, the buffer conditions used in the competitive dialysis experiments are not appropriate for 
NMR studies as the salt concentration is too high. NMR experiments were performed in 25 mM 
KH2PO4, 150 mM KCl and 1 mM EDTA. Competitive dialysis experiments for quindoline dimer, 
9, in both (dialysis and NMR) buffer conditions are included in the supplementary section (Figure 
1S). There are small changes but essentially the relative affinities are similar in both buffer 
conditions.  
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The spectra in H2O showed three signals, in the region of 11-12 ppm, belonging to Hoogsteen-
bound guanine imino proton of the G quartets (Fig. 3).  The addition of 9 to the quadruplex solution 
till a ratio R= [9]/[(T2AG3)4]=0.75 basically didn’t change the imino proton resonances but causes 
the appearance of two new down field signals (+0.3 ppm) belonging to a bound species in low 
chemical exchange.  Unfortunately the very low solubility of 9 in water precluded to continue the 
titration experiment. The non-exchangeable protons of the oligonucleotide showed the appearance 
of two new signals at 7.80 and 7.26 ppm, belonging to the drug, together with a signal at 8.40 ppm 
attributed to H8A3 in  the bound species (Fig. 1S).  The spectrum of the 9 without oligonucleotide, 
because of the high symmetry of the molecule showed only 4 signals on the aromatic protons region 
(Fig. 2S).  
                Despite this, NOESY spectra were acquired at R = [9]/[(T2AG3)4] = 0.5 and 0.75 that 
revealed few but significant contacts of 9 with T2, A3, G4, G5 and G6 protons indicating a binding 
to the quadruplex. Some examples are reported in Fig. 4 and Table 1 lists the NOE data and the 
distances values of the final structure obtained by MD. All the protons of the bound species were 
attributed and the assignments are reported in Table 2. 
A slight stabilization of the complex was proved by a melting experiment that resulted in an 
increase of the melting temperature (Tm ) in comparison with the free oligonucleotide (Fig. 5).  
The dimer structure of 9 was built using the fragment library in Insight II and Discover. 
Each fragment was optimized by conjugate algorithm and the resulting monomer was also 
optimized. The dimer was built by joining two monomers and the final structure was optimized 
once more. Analysis of the resulting geometries revealed that the energetically most favorable 
conformation was that in which the two aromatic rings adopt a folded  structure (Fig. 6) with a 
angle between aromatic systems around 60°, showing a π stack arrangement.  
The so-derived structure was then used as a starting point to study its interaction with the 
quadruplex by using a molecular docking experiment. Because of the interaction between the dimer 
structure of 9 and the quadruplex, all the conformation of the dimer obtained by molecular docking 
were found to be different than the structure previously optimized and used as a starting point in the 
calculation. Moreover, none of 9-quadruplex complexes resulting from the calculation has shown 
the ability of the 9 molecule to intercalate within the quadruplex, probably due to steric hindrance 
caused by the large size of the dimer.  
The analysis of the best solution obtained from molecular docking shows that the dimer 
molecule binds externally on the two opposite sides of the same strand, stabilized by π-π stacking 
interactions between the two aromatic rings of the dimer and the aromatic systems of the 
nucleotides, clamping one strand of the quadruplex (see fig. 7). By adopting this conformation, the 
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ligand is able to interact with T2, A3, G4 and G5 of various strands, a situation which leads to a 
significant stabilization of the complex in according the melting experiment. The complex is further 
stabilized by the presence of a strong hydrogen bond between the ligand amide nitrogen and the 
OP2 oxygen belonging to G4, at a distance of 2.25Å. 
           The goodness of this conformation was confirmed by NOE data with the distance calculated 
on the basis of the modeling obtained (Table 1). 
            We built the model of compound 3 and the quadruplex. It was energy-minimized and 
subjected to a restrained molecular dynamics calculations (MD). The resulting structure was used to 
obtain a prediction for the complex with the quadruplex structure, using again a molecular docking 
experiment. Unlike the previous case, the compound 3 behaves as a true intercalating agent, fitting 
completely within the quadruplex, in the pocket between the A3 and G4 units belonging to the four 
strands (fig. 8).  These results agree with the interaction between 5-N-Methyl quindoline derivatives 
and the same quadruplex structure already described in the literature [33, 34]. 
The resulting complex is only stabilized by π-π stacking interactions between the aromatic ring of 
the ligand and the rings of bases that are located above and below the molecule. The ability of the 3 
to fit within the quadruplex, and then to behave as a true intercalating agent, indirectly proves what 
has been stated before, namely that in the case of the dimer 9, this possibility is precluded only by 
steric factors and not by structural and/or electronic characteristics of the molecule. 
 
 3.3. 1H NMR Experiments on the [9]/[d(5’-CGA TCG-3’)2] complex.  
               The increase in the line broadening of the resonances of NHG2C5, NHA3T4 imino, 
aromatic and anomeric protons can easily be followed during the titration experiments with 9, as 
shown in Fig. 9. The imino proton NHC1G6 is difficult to monitor because of the fraying which 
involve the base pairs terminal ends. A slight shielding at maximum of 0.09 ppm was shown for the 
aromatic protons.  The protons were attributed and the assignments are reported in Table 2. The 
addition of 9 into double stranded oligonucleotide produces a generalized line broadening. The 1H 
NOESY spectra of the complex with 9 suggest, even with few number of NOEs interactions, the 
binding at the level of G2, C5 bases (H8G2/Har, H5and H6C5/Har).  
              The same titration experiment performed with 3 shows no line broadening of imino proton 
resonances and no chemical shift variations (Fig. 3S Supporting Information) even at high [3] / 
[d(5’-CGA TCG-3’)2] ratio. These observations suggest that compound 3 does not interact with 
short double helix oligonucleotides as it was also confirmed by 2D NOESY experiments which 
don’t show any contact points between drug and oligonucleotide.    
 
Conclusions 
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In summary we have used competitive dialysis experiments in order to determine the DNA 
binding properties of a complete series of 4-aminoproline oligomers carrying up to three units of 
acridine and quindoline molecule. A high selectivity of quindoline 4-aminoproline oligomers for G-
quadruplex and triplex structures was observed. Selectivity for quadruplex was also found for some 
acridine oligomers but the affinity was lower compared with quindoline oligomers.  The affinity of 
acridine 4-aminoproline oligomers was similar to the affinity described for acridine oligomers built 
on the 2-aminoethylglycine backbone [14] indicating that both backbones provide similar DNA-
binding properties to the resulting oligomers.  
A detailed NMR / molecular dynamics study on G-quadruplex telomeric sequence and the 4-
aminoproline dimer carrying two quindolines shows the reasons of the affinity of the quindoline 
dimer with the telomeric DNA quadruplex. First the most stable conformation of the quindoline 
dimer alone adopts a structure in which the two aromatic rings stack with an angle around 60º. This 
structure fits on the quadruplex clamping one strands and the complex is stabilized by π-π stacking 
interactions between the aromatic rings of the ligand and the nucleobases of the telomeric sequence 
that are located above and below the molecule. The results of this work and specially the model of 
the complex can be used for the design of new molecules with high affinity to telomeres which may 
have anticancer properties.  
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Table 1. Intermolecular NOE interactions and inter-proton distances (Å) for the complex of 9 with 
(T2AG3)4a 
          
 
 
 
 
 
 
 
 
 
a  Acquired at 25°C, H2O-D2O (90:10 v/v), pH 
6.7, 25 mM KH2PO4, 150 mM KCl and 1 mM 
EDTA. 2’-H and 2”-H stand  for low field and 
up field proton, respectively. 
 
b Obtained from the best structures of the 
complex resulting from the molecular docking 
studies. The distances are referred to the T1 –G6 
also in different strands (I and II).
 
    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
9 d(TTAGGG)4 db 
 H (7.80 ppm) 1’- H  A3 4.60 I 
   8- H   G4 5.06 II 
   2’-H   G4 5.20 II 
    2“-H   G5  4.38 II 
     
       
3’-H   G5 5.61 II 
 
4’-H   G5 3.58 I 
 
4’-H   G6 
CH3   T2 
4.95 II 
2.86 I 
H (7.26 ppm) 1’-H   A3 
1’-H   A3 
3.92 II 
5.18 I 
 
CH3   T2 3.75 I 
Distance violations (>0.3Å)  
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Table 2. 1H chemical shift values for the complexes d(5’-TTA GGG-3’)4a and  d(5’-CGA TCG-
3’)2b with 9. 
 
aMeasured at 25°C in ppm (δ) and referenced from external DSS, H2O- D2O  
(90:10 v/v), pH 6.7, 25 mM  KH2PO4, 150 mM KCl and 1 mM EDTA.  b Measured  
at 15°C in ppm (δ) and referenced from external DSS. Solvent H2O-D2O (90:10 v/v);  
pH 6.7,  R = [9] / [DNA]  = 1.  
Protons (TTAGGG)4/9 Protons (CGATCG)2/9 
NH G4 11.60 NHC1G6 n.d. 
NH G5 11.20 NHG2C5 12.92 
NH G6 10.51 NHA3T4 13.66 
6H T1 7.40 NH2 C1 8.28, 7.07 
6H T2 7.29 NH2 C5 8.63, 7.07 
8H A3 8.42 6H C1 7.67 
2H A3 8.05 8H G2 8.03 
8H G4 7.76 8H A3 8.34 
8H G5 7.48 2H A3 7.93 
8H G6 7.34 8H G6 8.00 
CH3 T1 1.67 6H T4 7.25 
CH3 T2 1.75 6H C5 7.53 
1’H T1 5.99 5H C1 6.00 
1’H T2 6.22 5H C5 5.70 
1’H A3 6.24 CH3 T4 1.45 
1’H G4 6.00 1’H C1 5.76 
1’H G5 6.00 1’H G2 5.91 
1’H G6 6.09 1’H A3 6.36 
2’2’’H T1 2.33, 2.08 1’H T4 6.00 
2’2’’H T2 2.33, 2.03 1’H C5 5.77 
2’2’’H A3 2.85, 2.85 1’H G6 6.20 
2’2’’H G4 2.80, 2.56 2’2’’H C1 2.45, 1.93     
2’2’’H G5 2.86, 2.69 2’2’’H G2 2.89, 2.78    
2’2’’H G6 2.83, 2.60 2’2’’H A3 3.02, 2.75 
3’H T1 4.65 2’2’’H T4 2.48, 2.07 
3’H T2 4.72 2’2’’H C5 2.40, 2.08 
3’H A3 5.08 2’2’’H G6 2.68, 2.41 
3’H G4 4.98 3’H C1 4.63 
3’H G5 5.02 3’H G2 5.04 
3’H G6 4.85 3’H A3 5.07 
4’H T1 3.98 3’H T4 5.08 
4’H T2 4.05 3’H C5 4.86 
4’H A3 4.44 3’H G6 4.72 
4’H G4 4.49 4’H C1 4.17 
4’H G5 4.30 4’H G2 n.d. 
4’H G6 4.47 4’H A3 4.53 
 
 5’5’’H C1 4.02 
 
 5’5’’H G2 4.02,  4.02 
 
 5’5’’H C5 4.20,  4.17 
 
 5’5’’H G6 4.12,  4.06 
 
 5’5’’H A3      4.28, 4.14 
 
 5’5’’H T4   4.34, 4.22 
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FIGURES 
 
Fig. 1: Structure of the acridine and quindoline derivates. 
 
 
 
 
      1: R= COOH     3: R= COOH 
          2:  R= CONHCH2COOH    4: R= CONHCH2COOH 
 
 
 
 
 
         
 
 
 
 
5, 6 and 7: n=1, 2 and 3   8, 9 and 10: n=1, 2 and 3 
  
 
 
 
 
 
 
 
11: R1= Acridine, R2= Quindoline                 13: R1= Acridine, R2= Acridine, R3= Quindoline       
12: R1= Quindoline, R2= Acridine    14: R1= Acridine, R2= Quindoline, R3=Acridine 
                                                                        1 5: R1= Quindoline, R2= Acridine, R3= Acridine 
 16: R1= Acridine, R2= Quindoline, R3= Quindoline 
  17: R1= Quindoline, R2= Quindoline, R3= Acridine 
                                                                         18: R1= Quindoline, R2= Acridina, R3= Quindoline 
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H
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Fig. 2. Results obtained by the competitive dialysis assay. The amount of ligand (Figure 1) bound to 
each DNA structure is shown as a bar graph. The nucleic acid names are given on the left, and 
structures are described in material and method section. The values are normalized for each 
compound. A) acridine derivatives: monomers 1, 2, 5, acridine dimer 6 and acridine trimer 7. B) 
quindoline derivatives: monomers 3, 4, 8, quindoline dimer 9 and quindoline trimer 10. C) dimers 
carrying acridine and quindoline 11, 12. D) trimers carrying acridine and quindoline 13-18. 
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Fig. 3. Low field region of 1H NMR spectra of (T2AG3)4/ 9 complex in H2O, 25 mM KH2PO4, 150 
mM KCl, 1 mM EDTA (pH 6.7), 25°C at different R = [9] / [(T2AG3)4]. The resonances belonging 
to the bound species are indicated by an asterisk. 
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Fig. 4: 2D NOESY spectrum of (T2AG3)4/ 9 complex at R = [9]/[(T2AG3)4]=0.75, 25 mM 
KH2PO4, 150 mM KCl and 1 mM EDTA (pH 6.7) at 25°C. Intra and inter residues interactions 
were shown. Extra aromatic protons of  9 and (T2AG3)4 contacts were observed with: (a) CH3T2, 
(b) H2’G5, (c) H2’G4 (d) CH3T2. 
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Fig. 5: Thermal denaturation of the parallel (T2AG3)4 quadruplex structure (25 mM KH2PO4, 150 
mM KCl and 1 mM EDTA, pH 6.7). On the left is shown the spectrum of DNA alone and on the 
right the spectrum of the complex with 9. 
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Fig. 6: Energy minimized structure of 9. 
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Fig. 7: Lateral (left) and upper (right) views of the 9-quadruplex best-solution obtained from 
molecular docking calculations. Both molecules are represented by their solvent accessible surfaces 
(SAS), green for the 9 molecule and yellow for the quadruplex (PDB code:1NP9). 
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Fig. 8: Schematic drawing of the lowest energy intercalation complex 3-quadruplex obtained from 
molecular docking calculation. The ligand is represented in stick, while quadruplex is in rings style, 
surrounded by the solvent accessible surface. 
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Fig. 9: Imino and aromatic protons region of 1H NMR spectra of d(5’-CGA TCG-3’)2/9 complex in 
H2O, 10 mM KH2PO4, 70 mM KCl and 0.2 mM EDTA (pH 7.0), 15°C at different R =[9]/[d(5’-
CGA TCG-3’)2].  
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Figure 1S. Competitive dialysis assay for compound 9. A) 185 mM NaCl, 185 mM KCl, 2 mM 
NaH2PO4, 1 mM EDTA and 6mM Na2HPO4 (same conditions than competitive dialysis 
experiments shown in Figure2)
. 
B) 25 mM KH2PO4, 150 mM KCl and 1 mM EDTA (same 
conditions than NMR studies). The oligonucleotide sequence T2AG3 used in NMR studies is 
included in addition to the oligonucleotides shown in Figure 2.   
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Figure 2S. Aromatic protons region of 1H NMR spectra of (T2AG3)4/ 9 complex in H2O, 25 mM 
KH2PO4, 150 mM KCl and 1 mM EDTA, pH 6.7, 25°C at different R = [9]/[ (T2AG3)4]: (a) 0, (b) 
0.25, (c) 0.5, (d) 0.75. 
 
 
 
 
 
 
 
Figure 3S.  Aromatic protons region of 1H NMR spectrum of 9 in D2O, 25 mM KH2PO4, 150 mM 
KCl and 1 mM EDTA, pH 6.7, 25°C. 
(a) 
(b) 
(c) 
(d) 
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Figure 4S. Imino and aromatic protons region of 1H NMR spectra of (CGATCG)2/ 3 complex in 
H2O, 10 mM KH2PO4, 70 mM KCl and 0.2 mM EDTA (pH 7.0), 15°C at different R = [3]/[ 
(CGATCG)2].  
 
 
 
